首页> 美国卫生研究院文献>other >Accelerated recovery of renal mitochondrial and tubule homeostasis with SIRT1/PGC-1α activation following ischemia-reperfusion injury
【2h】

Accelerated recovery of renal mitochondrial and tubule homeostasis with SIRT1/PGC-1α activation following ischemia-reperfusion injury

机译:缺血再灌注损伤后SIRT1 /PGC-1α激活可促进肾线粒体和肾小管稳态的恢复

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Kidney ischemia-reperfusion (I/R) injury elicits cellular injury in the proximal tubule, and mitochondrial dysfunction is a pathological consequence of I/R. Promoting mitochondrial biogenesis (MB) as a repair mechanism after injury may offer a unique strategy to restore both mitochondrial and organ function. Rats subjected to bilateral renal pedicle ligation for 22 min were treated once daily with the SIRT1 activator SRT1720 (5 mg/kg) starting 24h after reperfusion until 72h–144h. SIRT1 expression was elevated in the renal cortex of rats after I/R + vehicle treatment (IRV), but was associated with less nuclear localization. SIRT1 expression was even further augmented and nuclear localization was restored in the kidneys of rats after I/R + SRT1720 treatment (IRS). PGC-1α was elevated at 72h–144h in IRV and IRS kidneys; however, SRT1720 treatment induced deacetylation of PGC-1α, a marker of activation. Mitochondrial proteins ATP synthase β, COX I, and NDUFB8, as well as mitochondrial respiration, were diminished 24h–144h in IRV rats, but were partially or fully restored in IRS rats. Urinary kidney injury molecule-1 (KIM-1) was persistently elevated in both IRV and IRS rats; however, KIM-1 tissue expression was attenuated in IRS rats. Additionally, sustained loss of Na+,K+-ATPase expression and basolateral localization and elevated vimentin in IRV rats was normalized in IRS rats, suggesting restoration of a differentiated, polarized tubule epithelium. The results suggest that SRT1720 treatment expedited recovery of mitochondrial protein expression and function by enhancing MB, which was associated with faster proximal tubule repair. Targeting MB may offer unique therapeutic strategy following ischemic injury.
机译:肾脏缺血再灌注(I / R)损伤引起近端小管细胞损伤,线粒体功能障碍是I / R的病理结果。促进线粒体生物发生(MB)作为损伤后的修复机制可能提供独特的策略来恢复线粒体和器官功能。从再灌注后24小时开始直至72h至144h,将大鼠双侧肾蒂结扎22分钟,每天用SIRT1激活剂SRT1720(5 mg / kg)治疗一次。 I / R +媒介物处理(IRV)后,大鼠肾皮质中SIRT1表达升高,但与核定位较少相关。 I / R + SRT1720治疗(IRS)后,SIRT1的表达甚至进一步增强,并且在大鼠肾脏中恢复了核定位。 IRV和IRS肾脏中PGC-1α在72h至144h升高。然而,SRT1720处理可诱导PGC-1α脱乙酰化,PGC-1α是激活标记。在IRV大鼠中,线粒体蛋白ATP合酶β,COX I和NDUFB8以及线粒体呼吸作用在24h至144h减少,但在IRS大鼠中被部分或完全恢复。 IRV和IRS大鼠尿肾损伤分子1(KIM-1)持续升高;但是,IRS大鼠的KIM-1组织表达减弱。此外,IRS大鼠中Na + ,K + -ATPase表达的持续丢失,基底外侧定位和波形蛋白的升高已在IRS大鼠中恢复正常,这表明分化的极化小管得以恢复上皮。结果表明,SRT1720治疗通过增强MB加快了线粒体蛋白表达和功能的恢复,这与更快的近端肾小管修复有关。靶向MB可能在缺血性损伤后提供独特的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号